IMMUNOHISTOCHEMICAL LOCALIZATION OF CYTOCHROME-P450 3A IN HUMAN PULMONARY CARCINOMAS AND NORMAL BRONCHIAL TISSUE

被引:54
作者
KIVISTO, KT
FRITZ, P
LINDER, A
FRIEDEL, G
BEAUNE, P
KROEMER, HK
机构
[1] ROBERT BOSCH KRANKENHAUS,INST PATHOL,D-70376 STUTTGART,GERMANY
[2] DR MARGARETE FISCHER BOSCH INST CLIN PHARMACOL,STUTTGART,GERMANY
[3] KLIN SCHILLERHOHE,THORAXCHIRURG ABT,GERLINGEN,GERMANY
[4] INSERM,U75,PARIS,FRANCE
来源
HISTOCHEMISTRY AND CELL BIOLOGY | 1995年 / 103卷 / 01期
关键词
D O I
10.1007/BF01464472
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The cytochrome P450 (CYP) enzymes metabolize drugs and other xenobiotics in liver and also in some extrahepatic tissues. We have studied the expression and localization of CYP3A in primary lung rumours and normal lung tissue from the same patients. Thirty-two patients undergoing partial or total lung resection for therapy of primary pulmonary carcinoma were included in this study. Immunohistochemical staining for CYP3A was performed with a modification of the ABC technique. Eight of the 32 cases of primary pulmonary carcinoma showed expression of CYP3A. In 12 of the 32 cases of normal tissue, the seromucous glands were positive for CYP3A. The bronchial epithelium was positive for CYP3A in 11 cases. We observed no correlation between CYP3A expression in tumour tissue and that in seromucous glands or bronchial epithelium. We conclude that CYP3A is present in both normal and cancerous lung tissue. Our findings suggest, however, no co-expression of CYP3A in lung cancer.
引用
收藏
页码:25 / 29
页数:5
相关论文
共 19 条
[1]   THE PULMONARY UPTAKE, ACCUMULATION, AND METABOLISM OF XENOBIOTICS [J].
BEND, JR ;
SERABJITSINGH, CJ ;
PHILPOT, RM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1985, 25 :97-125
[2]  
CHANG TKH, 1993, CANCER RES, V53, P5629
[3]   ROUTES OF CONJUGATION IN NORMAL AND CANCEROUS-TISSUE FROM HUMAN-LUNG [J].
COHEN, GM ;
GIBBY, EM ;
MEHTA, R .
NATURE, 1981, 291 (5817) :662-664
[4]   IFOSFAMIDE MESNA - A REVIEW OF ITS ANTINEOPLASTIC ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY IN CANCER [J].
DECHANT, KL ;
BROGDEN, RN ;
PILKINGTON, T ;
FAULDS, D .
DRUGS, 1991, 42 (03) :428-467
[5]  
FRITZ P, 1993, HISTOCHEMISTRY, V99, P443
[6]  
FRITZ P, 1985, ZENTRALBL ALLG PATHO, V30, P187
[7]   HUMAN CYTOCHROMES-P450 - PROBLEMS AND PROSPECTS [J].
GONZALEZ, FJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (09) :346-352
[8]   PHARMACOGENETIC PHENOTYPING AND GENOTYPING - PRESENT STATUS AND FUTURE POTENTIAL [J].
GONZALEZ, FJ ;
IDLE, JR .
CLINICAL PHARMACOKINETICS, 1994, 26 (01) :59-70
[9]  
GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051
[10]  
GUENGERICH FP, 1993, DRUG METAB DISPOS, V21, P1